The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl

Matthew Budoff; Suvasini Lakshmanan; Deepak L. Bhatt

doi:10.1093/eurheartj/ehab233

The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl

Matthew Budoff, Suvasini Lakshmanan, Deepak L. Bhatt

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Original language	English
Pages (from-to)	3025-3026
Number of pages	2
Journal	European Heart Journal
Volume	42
Issue number	31
DOIs	https://doi.org/10.1093/eurheartj/ehab233
State	Published - 14 Aug 2021
Externally published	Yes

Access to Document

10.1093/eurheartj/ehab233

Cite this

@article{5d7a6f9df1974943b4fec4d671c29939,

title = "The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl",

author = "Matthew Budoff and Suvasini Lakshmanan and Bhatt, {Deepak L.}",

year = "2021",

month = aug,

day = "14",

doi = "10.1093/eurheartj/ehab233",

language = "English",

volume = "42",

pages = "3025--3026",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "31",

}

TY - JOUR

T1 - The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl

AU - Budoff, Matthew

AU - Lakshmanan, Suvasini

AU - Bhatt, Deepak L.

PY - 2021/8/14

Y1 - 2021/8/14

UR - http://www.scopus.com/inward/record.url?scp=85116957540&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehab233

DO - 10.1093/eurheartj/ehab233

M3 - Comment/debate

C2 - 33970207

AN - SCOPUS:85116957540

SN - 0195-668X

VL - 42

SP - 3025

EP - 3026

JO - European Heart Journal

JF - European Heart Journal

IS - 31

ER -